Organigram Holdings Inc. (TSE:OGI – Get Free Report) fell 0.4% during trading on Monday . The stock traded as low as C$2.18 and last traded at C$2.26. 174,291 shares changed hands during mid-day trading, a decline of 22% from the average session volume of 223,412 shares. The stock had previously closed at C$2.27.
Analyst Ratings Changes
Several equities research analysts have recently weighed in on the company. Canaccord Genuity Group reduced their price objective on Organigram from C$3.60 to C$3.15 and set a “speculative buy” rating for the company in a research report on Monday, December 9th. ATB Capital dropped their price objective on shares of Organigram from C$5.25 to C$3.50 in a report on Tuesday, December 17th.
View Our Latest Stock Analysis on Organigram
Organigram Trading Down 0.4 %
Insider Activity
In other news, Senior Officer Paolo De Luca sold 12,014 shares of the firm’s stock in a transaction dated Thursday, October 24th. The shares were sold at an average price of C$2.52, for a total value of C$30,275.28. 31.32% of the stock is owned by insiders.
Organigram Company Profile
Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O’ Buds, Monjour, Trailblazer, SHRED’ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.
Recommended Stories
- Five stocks we like better than Organigram
- What is the Dow Jones Industrial Average (DJIA)?
- 2 Stocks to Gain From Trump Universal Tariffs on Critical Imports
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Rigetti Computing, Inc.: Buy, Sell, or Hold for 2025
- What is a SEC Filing?
- Delta Can Fly to New Highs in 2025; Here’s Why
Receive News & Ratings for Organigram Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organigram and related companies with MarketBeat.com's FREE daily email newsletter.